Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aclarion (ACON) Research & Development (2021 - 2025)

Aclarion's Research & Development history spans 5 years, with the latest figure at $263130.0 for Q4 2025.

  • For Q4 2025, Research & Development rose 4.49% year-over-year to $263130.0; the TTM value through Dec 2025 reached $1.0 million, up 16.32%, while the annual FY2025 figure was $1.0 million, 16.32% up from the prior year.
  • Research & Development reached $263130.0 in Q4 2025 per ACON's latest filing, down from $302037.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $353226.0 in Q2 2022 to a low of $162714.0 in Q2 2021.
  • Average Research & Development over 5 years is $232586.8, with a median of $219838.0 recorded in 2022.
  • Peak YoY movement for Research & Development: soared 117.08% in 2022, then plummeted 31.86% in 2023.
  • A 5-year view of Research & Development shows it stood at $182101.0 in 2021, then rose by 20.26% to $218997.0 in 2022, then grew by 0.77% to $220679.0 in 2023, then grew by 14.11% to $251826.0 in 2024, then rose by 4.49% to $263130.0 in 2025.
  • Per Business Quant, the three most recent readings for ACON's Research & Development are $263130.0 (Q4 2025), $302037.0 (Q3 2025), and $270434.0 (Q2 2025).